We Manufacture Products That Change Lives™

Life changing perinatal tissue allografts based on our proprietary BioREtain® process.

ABOUT US

Best-In-Class Perinatal Tissue Allografts

  • BioStem Technologies® produces innovative perinatal tissue-based allografts.
  • Our membrane allografts are manufactured using our proprietary BioREtain® processing method that preserves the quality of the tissue.
  • In our AATB® accredited, FDA® registered, cGMP compliant lab, we strive to provide products and services that adhere to Current Good Tissue Practice requirements.
ABOUT US

Best-In-Class Perinatal Tissue Allografts

  • BioStem Technologies® produces innovative perinatal tissue-based allografts.
  • Our membrane allografts are processed using our proprietary BioREtain® processing method that preserves the biologic quality of the tissue.
  • In our AATB® accredited, FDA® registered, cGMP compliant lab, we strive to provide products and services that adhere to Current Good Tissue Practice requirements.
Working with us

Why Choose Us

Who We Are

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies.

Why BioStem

Our allografts are processed utilizing our proprietary BioREtain® method, which focuses on preserving the tissue’s endogenous biological properties while maintaining the structure and matrix found in fresh perinatal tissue.

Our Goal

BioStem is committed to improving patients’ quality of life through scientific innovation and strict adherence to our quality system.

How We Help

Latest News

Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award Winner

Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award Winner

Award celebrates bold leaders shaping the future through the world’s most ground-breaking companies. Source: BioStem Technologies, Inc. POMPANO BEACH, Fla., June 17, 2025 (GLOBE NEWSWIRE) — Ernst & Young LLP (EY US) announced that Jason Matuszewski, CEO and Chairman of the Board of BioStem Technologies (OTC: BSEM), was named an Entrepreneur Of The Year 2025 Florida Award winner. Entrepreneur Of The Year is the preeminent competitive awards program for entrepreneurs and leaders…

Stay In Touch

Subscribe To Our Newsletter

To stay up to date on all of our news, products, and achievements, please subscribe to our newsletter.

Our Social Media: